NORCH Bulletin April 2019 Research Spotlight: SGLT2 Inhibition Reprograms Systemic Metabolism via FGF21-Dependent and – Independent Mechanisms  Sodium/glucose cotransporter-2 (SGLT2) inhibitors are a relatively new class of antidiabetic medications that inhibit renal glucose reabsorption, increasing glucosuria and lowering serum glucose. More recently, SGLT2 … Continued

NORCH Bulletin February 2019 Featured: Harrison DE, Strong R, Alavez S, Astle CM, DiGiovanni J, Fernandez E, Flurkey K, Garratt M, Gelfond JAL, Javors MA, Levi M, Lithgow GJ, Macchiarini F, Nelson JF, Sukoff Rizzo SJ, Slaga TJ, Stearns T, … Continued